GlassScriptPhysician profile
Kelsey Armstrong
NPI 1659871648
$2,247.19
in general payments reported to CMS, 2019-2025
21 companies · $1,423 in 2025
The $1,423 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.70 · 2023: $346 · 2024: $438 · 2025: $1,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,207.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $494.80 | 2023-2025 | Lifevest |
| Abiomed | $346.55 | 2024-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.35 | 2023-2025 | Jardiance |
| Medtronic, INC. | $147.75 | 2025 | Closurefast |
| Merck Sharp & Dohme LLC | $137.27 | 2023-2025 | Verquvo, Winrevair |
| Stryker Corporation | $135.88 | 2025 | Flowtriever, Venacore Thrombectomy Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $128.15 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $117.75 | 2025 | Camzyos, Eliquis |
| Pfizer INC. | $106.48 | 2024-2025 | |
| Cvrx, INC. | $70.74 | 2024-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $69.69 | 2023-2025 | |
| Novo Nordisk INC | $67.49 | 2024-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $42.87 | 2023 | Xarelto |
| Scpharmaceuticals INC. | $42.75 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $39.70 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $39.51 | 2024 | |
| Kestra Medical Technology Services, INC. | $29.21 | 2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $21.91 | 2023 | Opsumit, Uptravi |
| United Therapeutics Corporation | $20.95 | 2023 | Tyvaso |
| Paratek Pharmaceuticals, INC. | $16.44 | 2025 | Nuzyra |
| Kiniksa Pharmaceuticals, LTD. | $15.95 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.